FRAMINGHAM, Mass., Dec. 6 /PRNewswire/ -- Transport Pharmaceuticals, Inc., a leader in combination drug/medical devices for the topical treatment of dermatological conditions, today announced that it has been awarded the 2007 Frost & Sullivan North American Technology Innovation of the Year Award for its work in electrokinesis-enabled drug delivery. Frost & Sullivan, a global- growth consulting company, honored Transport at its annual North American Excellence in Healthcare Opportunities Awards Banquet, December 5, 2007 in Orlando, Florida.
Frost & Sullivan has recognized Transport with this prestigious innovation award for making "significant contributions in enhancing the delivery of topically applied dermatologic drugs." Transport's lead product, the SoloVir(TM) Electrokinetic Transdermal System (SoloVir(TM) ETS), may represent a significant breakthrough in the treatment of herpes labialis, also known as cold sores. SoloVir(TM) ETS enables the delivery of the company's novel five- percent acyclovir gel formulation by means of electric current via a small, finger mounted, microprocessor-driven control unit with a single-use, unit- dose drug cartridge. This innovative design allows patients to safely self- administer the drug, exactly where, and when it is needed.
Dennis I. Goldberg, Ph.D., President and Chief Executive Officer of
Transport, commented on the award, "It is a great honor to receive this
award from the respected Frost and Sullivan organization. I am pleased to
accept this award on behalf of Transport and recognize the team that makes
our unique drug/device combination products a reality. It's not just
management and investors; it's the engineers, chemists, biologists,
clinical development, regulatory and quality assurance experts who have
contributed to our continued success. The convergence of all of these
disciplines into a highly focused company is what distinguishes Transport
Pharmaceuticals from the competition. It is gratify
|SOURCE Transport Pharmaceuticals|
Copyright©2007 PR Newswire.
All rights reserved